{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:39:56Z","timestamp":1794447596939,"version":"4.9.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:00:00Z","timestamp":1523577600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BE 5437\/1-1+2"],"award-info":[{"award-number":["BE 5437\/1-1+2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006315","name":"Reumafonds","doi-asserted-by":"publisher","award":["RF15-2-403"],"award-info":[{"award-number":["RF15-2-403"]}],"id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00742","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:18:14Z","timestamp":1523578694000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":68,"title":["Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models"],"prefix":"10.3389","volume":"9","author":[{"given":"Claire E. J.","family":"Waterborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Beermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathijs G. A.","family":"Broeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda B.","family":"Bennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije I.","family":"Koenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L. E. M.","family":"van Lent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim B.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"van der Kraan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fons A. J.","family":"van de Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/berh.1999.0047","article-title":"Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I","volume":"13","author":"Van Den Berg","year":"1999","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"Mcinnes","year":"2011","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.crohns.2012.06.024","article-title":"The complexity of adverse side-effects to biological agents","volume":"7","author":"Aubin","year":"2013","journal-title":"J Crohns Colitis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/gast.1997.v113.pm9247454","article-title":"Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn\u2019s disease. Crohn\u2019s Disease Study Group","volume":"113","author":"Van Deventer","year":"1997","journal-title":"Gastroenterology"},{"key":"B6","first-page":"648","article-title":"Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation","volume":"30","author":"Van Roon","year":"2004","journal-title":"J Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.03385","article-title":"Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities","volume":"3","author":"Lew","year":"2014","journal-title":"Elife"},{"key":"B8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2009.06.018","article-title":"Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR","volume":"31","author":"Gonzalez","year":"2009","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-immunol-032414-112103","article-title":"TAM receptor signaling in immune homeostasis","volume":"33","author":"Rothlin","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM receptors are pleiotropic inhibitors of the innate immune response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nri2303","article-title":"Immunobiology of the TAM receptors","volume":"8","author":"Lemke","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1189\/jlb.0909610","article-title":"TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes\/macrophages","volume":"87","author":"Alciato","year":"2010","journal-title":"J Leukoc Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.coi.2010.10.001","article-title":"TAM receptor signaling and autoimmune disease","volume":"22","author":"Rothlin","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2567.2011.03511.x","article-title":"Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages","volume":"135","author":"Deng","year":"2012","journal-title":"Immunology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"a009076","DOI":"10.1101\/cshperspect.a009076","article-title":"Biology of the TAM receptors","volume":"5","author":"Lemke","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/art.37786","article-title":"Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis","volume":"65","author":"Van Den Brand","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1002\/art.24072","article-title":"Splenic suppressor of cytokine signaling 3 transgene expression affects T cell responses and prevents development of collagen-induced arthritis","volume":"58","author":"Veenbergen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"33335","DOI":"10.1074\/jbc.M111.263020","article-title":"Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cdelta, and p38 mitogen-activated protein kinase (MAPK)","volume":"286","author":"Thorp","year":"2011","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2006-05-021634","article-title":"A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation","volume":"109","author":"Sather","year":"2007","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12969-015-0007-y","article-title":"Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus","volume":"13","author":"Ballantine","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1073\/pnas.1524292113","article-title":"MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation","volume":"113","author":"Cai","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/ar3316","article-title":"Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"R212","DOI":"10.1186\/ar4407","article-title":"Circulating levels of soluble MER in lupus reflect M2c activation of monocytes\/macrophages, autoantibody specificities and disease activity","volume":"15","author":"Zizzo","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17111807","article-title":"The Gas6\/TAM system and multiple sclerosis","volume":"17","author":"Bellan","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1172\/JCI90520","article-title":"MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis","volume":"127","author":"Cai","year":"2017","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/cei.13082","article-title":"Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction","volume":"192","author":"Xu","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/19554","article-title":"Tyro-3 family receptors are essential regulators of mammalian spermatogenesis","volume":"398","author":"Lu","year":"1999","journal-title":"Nature"},{"key":"B28","first-page":"283","article-title":"Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay","volume":"15","author":"Carr","year":"2009","journal-title":"Mol Vis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jim.2008.11.019","article-title":"A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester","volume":"342","author":"Miksa","year":"2009","journal-title":"J Immunol Methods"},{"key":"B30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0002-9440(10)62961-6","article-title":"Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1","volume":"167","author":"Koenders","year":"2005","journal-title":"Am J Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/ni.2986","article-title":"Diversification of TAM receptor tyrosine kinase function","volume":"15","author":"Zagorska","year":"2014","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/art.27285","article-title":"Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture","volume":"62","author":"Kiener","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13075-016-1083-1","article-title":"Suppression of the inflammatory response by disease-inducible interleukin-10 gene therapy in a three-dimensional micromass model of the human synovial membrane","volume":"18","author":"Broeren","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1073\/pnas.78.4.2512","article-title":"High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein","volume":"78","author":"Dahlback","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"crossref","first-page":"12022","DOI":"10.1016\/S0021-9258(18)67196-0","article-title":"Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein","volume":"261","author":"Dahlback","year":"1986","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1016\/S0021-9258(18)37818-9","article-title":"Novel subunit in C4b-binding protein required for protein S binding","volume":"263","author":"Hillarp","year":"1988","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0038-1646373","article-title":"Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system","volume":"66","author":"Dahlback","year":"1991","journal-title":"Thromb Haemost"},{"key":"B38","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood.V79.12.3203.3203","article-title":"Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin","volume":"79","author":"Griffin","year":"1992","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","article-title":"Secondary necrosis: the natural outcome of the complete apoptotic program","volume":"584","author":"Silva","year":"2010","journal-title":"FEBS Lett"},{"key":"B40","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/cddiscovery.2015.56","article-title":"Secondary necrotic neutrophils release interleukin-16C and macrophage migration inhibitory factor from stores in the cytosol","volume":"1","author":"Roth","year":"2015","journal-title":"Cell Death Discov"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1002\/eji.200526167","article-title":"A crucial role for macrophages in the pathology of K\/B x N serum-induced arthritis","volume":"35","author":"Solomon","year":"2005","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1365-2249.1998.00529.x","article-title":"B cell-deficient mice do not develop type II collagen-induced arthritis (CIA)","volume":"111","author":"Svensson","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/intimm\/11.7.1065","article-title":"Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice","volume":"11","author":"Corthay","year":"1999","journal-title":"Int Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.neuron.2012.10.015","article-title":"Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis","volume":"76","author":"Burstyn-Cohen","year":"2012","journal-title":"Neuron"},{"key":"B46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature17630","article-title":"TAM receptors regulate multiple features of microglial physiology","volume":"532","author":"Fourgeaud","year":"2016","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/BF00915708","article-title":"Rheumatoid arthritis. The role of neutrophil activation","volume":"8","author":"Weissmann","year":"1984","journal-title":"Inflammation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1189\/jlb.70.5.708","article-title":"Uptake of apoptotic leukocytes by synovial lining macrophages inhibits immune complex-mediated arthritis","volume":"70","author":"Van Lent","year":"2001","journal-title":"J Leukoc Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.pathmechdis.3.121806.151456","article-title":"The inflammatory response to cell death","volume":"3","author":"Rock","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.4049\/jimmunol.164.9.4429","article-title":"Cutting edge: CD4 is not required for the functional activity of IL-16","volume":"164","author":"Mathy","year":"2000","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/rheumatology\/40.4.474","article-title":"Correlation of circulating interleukin 16 with proinflammatory cytokines in patients with rheumatoid arthritis","volume":"40","author":"Kaufmann","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"B52","first-page":"35","article-title":"Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis","volume":"31","author":"Lard","year":"2004","journal-title":"J Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cyto.2015.12.002","article-title":"Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis","volume":"78","author":"Murota","year":"2016","journal-title":"Cytokine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/annrheumdis-2012-202907","article-title":"Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis","volume":"73","author":"Ruiz-Heiland","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0002-9440(10)65369-2","article-title":"Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway","volume":"154","author":"O\u2019donnell","year":"1999","journal-title":"Am J Pathol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00742\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T08:30:22Z","timestamp":1660897822000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00742\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,13]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2018.00742"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00742","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2018.00742.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2018.00742.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2018.00742.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2018.00742.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2018.00742.s005","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,13]]},"article-number":"742"}}